Dr. Jim Huang

N. Brunswick, New Jersey, United States
Dr. Huang founded Ascendia after fifteen years of pharmaceutical R&D experience at Pfizer, Baxter, AstraZeneca, and Roche. He has led the formulation development efforts for the successful transition of several oral and parenteral dosage forms from discovery through formulation, manufacturing, technical transfer and ultimately commercialization. Dr. Huang holds a Ph.D. in Pharmaceutics from the University of the Sciences in Philadelphia (formerly Philadelphia College of Pharmacy and Sciences) where he worked with Joseph B. Schwartz. Dr. Huang’s research interests are centered on improvement of solubility and dissolution, and controlled delivery of poorly water soluble drugs through nano-emulsion, nanoparticles, and amorphous technologies.
Speaking In
3:45 PM - 4:00 PM
Monday, June 3
Ascendia specializes in the application of nano-technology approaches to developing novel…